Methodology

All entries for: Curlim S.A.S

October 22, 2025

Curlim S.A.S

Orphan Drug Designation

FDA orphan drug designation: treatment of Charcot-Marie-Tooth disease (CMT)

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top